These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1172 related articles for article (PubMed ID: 15577686)

  • 21. Incidence and Pattern of Spread of Lymph Node Metastasis in Patients With Low-grade Serous Ovarian Cancer.
    Wafa M; Braicu EI; Muallem MZ; Richter R; Taube E; Sehouli J; Grabowski JP
    Anticancer Res; 2019 Oct; 39(10):5617-5621. PubMed ID: 31570458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serous cystadenocarcinoma of the ovary with simultaneous breast metastases. Description of a case].
    Manini C; Pietribiasi F; Sapino A; Donadio S
    Pathologica; 1998 Apr; 90(2):152-5. PubMed ID: 9619059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast-Report of two cases and literature review.
    Panse G; Bossuyt V; Ko CJ
    J Cutan Pathol; 2018 Mar; 45(3):234-239. PubMed ID: 29194708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Well-differentiated serous ovarian carcinoma presenting as a breast mass: a case report and flow cytometric DNA study.
    Frauenhoffer EE; Ro JY; Silva EG; el-Naggar A
    Int J Gynecol Pathol; 1991; 10(1):79-87. PubMed ID: 2007537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases.
    Raju U; Fine G; Greenawald KA; Ohorodnik JM
    Hum Pathol; 1989 May; 20(5):426-36. PubMed ID: 2707793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collision metastasis of breast and ovarian adenocarcinoma in axillary lymph nodes: a case report and review of the literature.
    Sughayer MA; Zakarneh L; Abu-Shakra R
    Pathol Oncol Res; 2009 Sep; 15(3):423-7. PubMed ID: 19067238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?
    Saiz E; Toonkel R; Poppiti RJ; Robinson MJ
    Cancer; 1999 May; 85(10):2206-11. PubMed ID: 10326699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review.
    Susini T; Olivieri S; Molino C; Castiglione F; Tavella K; Viligiardi R
    J Womens Health (Larchmt); 2010 Jan; 19(1):169-74. PubMed ID: 20088673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
    Seidman JD; Kurman RJ
    Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer.
    Chen S; Dai X; Gao Y; Shen F; Ding J; Chen Q
    Sci Rep; 2017 Dec; 7(1):16922. PubMed ID: 29208958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer.
    Grabowski JP; Glajzer J; Richter R; Plett H; Muallem MZ; Braicu EI; Taube E; Sehouli J
    Int J Gynecol Cancer; 2021 Jan; 31(1):98-103. PubMed ID: 33127866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
    Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
    Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.